Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.

Miguel-Angel Perales | Jianda Yuan | Sarah Powel | Humilidad F Gallardo | Teresa S Rasalan | Christina Gonzalez | Gregor Manukian | Jian Wang | Yan Zhang | Paul B Chapman | Susan E Krown | Philip O Livingston | Samuel Ejadi | Katherine S Panageas | Manuel E Engelhorn | Stephanie L Terzulli | Alan N Houghton | Jedd D Wolchok
Molecular therapy : the journal of the American Society of Gene Therapy | 2008

Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances immune responses by inducing proliferation, maturation, and migration of dendritic cells (DCs) as well as expansion and differentiation of B and T lymphocytes. The potency of DNA vaccines can be enhanced by the addition of DNA encoding cytokines, acting as molecular adjuvants. We conducted a phase I/II trial of human GM-CSF DNA in conjunction with a multipeptide vaccine (gp100 and tyrosinase) in stage III/IV melanoma patients. Nineteen human leukocyte antigen (HLA)-A*0201+ patients were treated. Three dose levels were studied: 100, 400, and 800 microg DNA/injection, administered subcutaneously every month with 500 microg of each peptide. In the dose-ranging study, three patients were treated at each dose level. The remaining patients were then treated at the highest dose. Most toxicities were grade 1 injection-site reactions. Eight patients (42%) developed CD8+ T-cell responses, defined by a > or =3 SD increase in baseline reactivity to tyrosinase or gp100 peptide in tetramer or intracellular cytokine staining (ICS) assays. There was no relationship between dose and T-cell response. Responding T cells had an effector memory cell phenotype. Polyfunctional T cells were also demonstrated. At a median of 31 months follow-up, median survival has not been reached. Human GM-CSF DNA was found to be a safe adjuvant.

Pubmed ID: 18797450

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: P01 CA059350
  • Agency: NCI NIH HHS, United States
    Id: CA59350
  • Agency: NCI NIH HHS, United States
    Id: CA33049
  • Agency: NCI NIH HHS, United States
    Id: K08 CA102606
  • Agency: NCI NIH HHS, United States
    Id: P01 CA033049-20
  • Agency: NCI NIH HHS, United States
    Id: K08 CA102606-01
  • Agency: NCI NIH HHS, United States
    Id: P01 CA033049
  • Agency: NCI NIH HHS, United States
    Id: CA10260
  • Agency: NCI NIH HHS, United States
    Id: P01 CA059350-11

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


U.S. Food and Drug Administration (tool)

RRID:SCR_012945

An agency of the United States Department of Health and Human Services, one of the United States federal executive departments that is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics and veterinary products. The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction. (Wikipedia)

View all literature mentions

PING (tool)

RRID:SCR_005394

Software program for probabilistic inference of ChIP-Seq using an empirical Bayes mixture model approach.

View all literature mentions